摘要
背景:阿尔茨海默病(AD)是最常见的与年龄有关的神经退行性疾病。它代表了所有痴呆的70%。全世界有数百万人受到广告的影响。它是一种复杂的疾病,其特征是淀粉样蛋白聚集物和神经原纤维缠结含有高度磷酸化的神经元tau蛋白。 AD需要能够规避血脑屏障(BBB)的药物,BBB不是血脑间简单的物理屏障,而是作为铁幕,只允许选择性分子进入大脑。不幸的是,这种动态屏障限制了药物向大脑的转运;由此,目前很少有药物可用于AD治疗。 目的:本研究主要集中在中枢神经系统旁路给BBB治疗AD的药物治疗策略。 结果:许多研究证明,通过使用不同的策略,有效地克服BBB和将药物靶向CNS。在这里我们已经讨论了一些最重要的药物渗透性和药物靶向方法。 结论:总而言之,仅仅关注药物开发项目的开发是不够的,但是在AD患者的中枢神经系统更为具体和有效的药物发现和给药系统之间保持平衡是非常重要的。
关键词: 阿尔茨海默病,血脑屏障,脑药物递送,药物渗透性,中枢神经系统,AD治疗。
图形摘要
Current Drug Targets
Title:The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview
Volume: 19 Issue: 2
关键词: 阿尔茨海默病,血脑屏障,脑药物递送,药物渗透性,中枢神经系统,AD治疗。
摘要: Background: Alzheimer's disease (AD) is the most frequent age related neurodegenerative disorder. It represents 70% of all dementia. Millions of people have been affected by AD worldwide. It is a complex illness characterized pathologically by accumulation of protein aggregates of amyloid and neurofibrillary tangles containing hyperphosphorylated neuronal tau protein. AD requires drugs that can circumvent the blood–brain barrier (BBB) which is not a simple physical barrier between blood and brain, but acts as an iron curtain, allowing only selective molecules to enter the brain. Unfortunately, this dynamic barrier restricts transport of drugs to the brain; due to which, currently very few drugs are available for AD treatment.
Objective: The present review focuses mainly on strategies used for administration of drug to the CNS by-passing BBB for the treatment of AD.
Results: Many studies have proved to be effective in overcoming BBB and targeting drugs to CNS by using different strategies. Here we have discussed some of the most important drug permeability and drug targeting approaches.
Conclusion: In conclusion, concentrating solely in development of drug discovery programs is not enough but it is important to maintain balance between the drug discovery and drug delivery systems that are more specific and effective in targeting CNS of AD patients.
Export Options
About this article
Cite this article as:
The Blood Brain Barrier and its Role in Alzheimer's Therapy: An Overview, Current Drug Targets 2018; 19 (2) . https://dx.doi.org/10.2174/1389450118666170612100750
DOI https://dx.doi.org/10.2174/1389450118666170612100750 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Computer-AidedCognitive Training Program for Elderly and Its Effectivenessthrougha 6 Months Group Intervention Study
Current Alzheimer Research Risk Factors of Alzheimers Disease Among Iranian Population
Current Alzheimer Research Recent Advances in Medicinal Chemistry and Pharmaceutical Technology- Strategies for Drug Delivery to the Brain
Current Topics in Medicinal Chemistry Partial Dopamine Agonists and Dopaminergic Stabilizers, in the Treatment of Psychosis
Current Drug Targets - CNS & Neurological Disorders Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications
Current Pharmaceutical Design Connections Between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis
Current Alzheimer Research Involvement of Gaucher Disease Mutations in Parkinson Disease
Current Protein & Peptide Science Effects of Snake Venom Polypeptides on Central Nervous System
Central Nervous System Agents in Medicinal Chemistry Haptoglobin Polymorphism and Lacunar Stroke
Current Neurovascular Research The Potential Mechanisms of Exercise-induced Cognitive Protection: A Literature Review
Current Pharmaceutical Design Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets Chemical and Pharmacological Significance of Natural Guanidines from Marine Invertebrates
Mini-Reviews in Medicinal Chemistry Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
Current Pharmaceutical Design Substance Abuse, HIV-1 and Hepatitis
Current HIV Research The Implications of Sortilin/Vps10p Domain Receptors in Neurological and Human Diseases
CNS & Neurological Disorders - Drug Targets MicroRNAs in Atrial Fibrillation
Current Medicinal Chemistry Effects of Resveratrol and Other Polyphenols on the Most Common Brain Age-Related Diseases
Current Medicinal Chemistry Disruption of Circadian Rhythms and Delirium, Sleep Impairment and Sepsis in Critically ill Patients. Potential Therapeutic Implications for Increased Light-Dark Contrast and Melatonin Therapy in an ICU Environment
Current Pharmaceutical Design Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes Aβ Deposition: Towards a Physiologic Animal Model of Alzheimers Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Cross Currents in Protein Misfolding Disorders: Interactions and Therapy
CNS & Neurological Disorders - Drug Targets